BMC Cancer
(Apr 2020)
Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
- Ryota Tamura,
- Yukina Morimoto,
- Kenzo Kosugi,
- Mizuto Sato,
- Yumiko Oishi,
- Ryo Ueda,
- Ryogo Kikuchi,
- Hideaki Nagashima,
- Tetsuro Hikichi,
- Shinobu Noji,
- Yutaka Kawakami,
- Hikaru Sasaki,
- Kazunari Yoshida,
- Masahiro Toda
Affiliations
- Ryota Tamura
- Department of Neurosurgery, Keio University School of Medicine
- Yukina Morimoto
- Department of Neurosurgery, Keio University School of Medicine
- Kenzo Kosugi
- Department of Neurosurgery, Keio University School of Medicine
- Mizuto Sato
- Department of Neurosurgery, Keio University School of Medicine
- Yumiko Oishi
- Department of Neurosurgery, Keio University School of Medicine
- Ryo Ueda
- Department of Neurosurgery, Keio University School of Medicine
- Ryogo Kikuchi
- Department of Neurosurgery, Hiratsuka City Hospital
- Hideaki Nagashima
- Department of Neurosurgery, Keio University School of Medicine
- Tetsuro Hikichi
- OncoTherapy Science
- Shinobu Noji
- Division of Cellular Signaling Institute for Advanced Medical Research, Keio University School of Medicine
- Yutaka Kawakami
- Division of Cellular Signaling Institute for Advanced Medical Research, Keio University School of Medicine
- Hikaru Sasaki
- Department of Neurosurgery, Keio University School of Medicine
- Kazunari Yoshida
- Department of Neurosurgery, Keio University School of Medicine
- Masahiro Toda
- Department of Neurosurgery, Keio University School of Medicine
- DOI
-
https://doi.org/10.1186/s12885-020-06783-8
- Journal volume & issue
-
Vol. 20,
no. 1
pp.
1
– 1
Abstract
Read online
Following publication of the original article [1], the authors reported an error in the author group.
WeChat QR code
